Results 51 to 60 of about 1,331 (184)

Role of Non‐Thermal Processing Technologies in Modulating Protein Allergenicity in Legumes

open access: yesFood Science &Nutrition, Volume 14, Issue 9, September 2026.
Non‐thermal processing technologies (NTTs) reduce legumes' allergenicity while preserving quality and nutrients retention (PEF, pulsed electric field; CP, cold plasma; HPP, high pressure processing; US, ultrasound; IR, infrared). ABSTRACT The global shift toward plant‐based diets has increased legume consumption due to health and environmental benefits.
Viateur Ngabonzima   +3 more
wiley   +1 more source

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

open access: yesAustralasian Journal of Dermatology, Volume 67, Issue 5, Page 301-308, August 2026.
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim   +7 more
wiley   +1 more source

Looper mice display blepharoconjunctivitis.

open access: yes, 2014
A–C) Photograph of the eyes of a Chd7+/+ mouse compared with those of two affected Chd7+/Looper mice. Chd7+/Looper mice exhibited lid oedema, narrowed palpebral fissures (B) and blepharoconjunctivitis (C). Mice ages were 7.5 weeks (A, B) and 10 weeks (C).
Benjamin T. Kile (54260)   +5 more
core   +1 more source

Rationale for the treatment of chronic blepharoconjunctivitis and meibomian gland dysfunction

open access: yesРоссийский офтальмологический журнал
Chronic blepharoconjunctivitis, often combined with meibomian gland dysfunction (MGD), disrupts the homeostasis of the ocular surface. Traditional diagnostics of microbiocenosis is insufficient, therefore gas chromatography-mass spectrometry (GC-MS ...
T. N. Safonova   +2 more
doaj   +1 more source

Homozygous Pathogenic Variant in Elongation Factor‐Like 1 (EFL1) as a Causal Factor in Shwachman‐Diamond Syndrome 2 in a Palestinian Child, With Distinct Ocular Manifestations

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 5, May 2026.
We report a Palestinian female infant with a homozygous pathogenic EFL1 variant (c.3284G>A; p.Arg1095Gln) causing Shwachman–Diamond syndrome type 2 (SDS2). Beyond the classical features of pancytopenia, exocrine pancreatic insufficiency, and growth failure, the patient showed previously unreported ocular manifestations—stage 2–3 retinopathy of ...
Ibrahim Taha   +13 more
wiley   +1 more source

Modern Aspects of Etiopathogenetic Treatment of Ophthalmodemodicosis (Literature Review)

open access: yesOftalʹmologiâ, 2018
Demodicosis is one of most spread dermatosis. Blepharitis of Demodectic etiology occupy from 39 to 88% among all inflammatory diseases of the eyelids. The disease is widespread, 89% of patients are parasite carriers, despite the fact that most of them do
A. D. Chuprov, E. K. Malgina
doaj   +1 more source

Preferred practice patterns and review on rosacea

open access: yesIndian Journal of Ophthalmology, 2023
Rosacea is a chronic, inflammatory facial dermatosis commonly found in fair skin tone population. Recent studies have shown the increasing prevalence in the dark skin tone population as well.
Nikunj V Patel   +2 more
doaj   +1 more source

Ocular manifestations of rosacea: A clinical review

open access: yes, 2021
Ocular rosacea is a chronic inflammatory condition that can occur in the absence of cutaneous features. The most common ocular features are chronic blepharoconjunctivitis with eyelid margin inflammation and meibomian gland dysfunction.
Tavassoli, S, Wong, N, Chan, E
core   +1 more source

The Antibacterial Eye Ointments in the Treatment of Eyelids and Conjunctiva Acute and Chronic Diseases

open access: yesOftalʹmologiâ, 2019
Currently, there are many studies on the effectiveness of ointment ophthalmological medicines. Ophthalmic ointments are unique because they have a multi-component action mechanism.
V. N. Trubilin   +5 more
doaj   +1 more source

Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions

open access: yesAllergy, Volume 81, Issue 2, Page 326-344, February 2026.
ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy